KBR Investor News: If You Have Suffered Losses in KBR, Inc. (NYSE: KBR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

KBR Investor News: If You Have Suffered Losses in KBR, Inc. (NYSE: KBR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire August 24, 2025 NEW YORK, Aug. 24, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf […]

Levi & Korsinsky Investigating Whether The J. M. Smucker Company (SJM) Misled Investors – Securities Law Violations Possible

NEW YORK, NY / ACCESS Newswire / August 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of The J. M. Smucker Company ("The J. M. Smucker Company") (NYSE:SJM) concerning possible violations of federal securities laws. On June 9, 2025, Smucker announced its fourth quarter and full fiscal year 2025

Historical contribution of China theater in the World Anti-Fascist War: Global Times

The year 1945 marked a great turning point in history. After 14 years of resistance in China, 10 years in Ethiopia, six years in Britain and other Western European countries, and four years in the Soviet Union, the US, Southeast Asia, and the Pacific, the world finally secured victory in the World Anti-Fascist War. Eighty

Levi & Korsinsky Investigates Possible Securities Fraud by LifeMD, Inc. (LFMD)

NEW YORK, NY / ACCESS Newswire / August 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeMD, Inc. ("LifeMD, Inc.") (NASDAQ:LFMD) concerning possible violations of federal securities laws. LifeMD announced its second quarter 2025 results on August 5, 2025. Among other items, the Company revealed that higher customer

Securities Class Action Lawsuit Filed Against C3.ai, Inc. (AI) – Levi & Korsinsky Represents Shareholders

NEW YORK, NY / ACCESS Newswire / August 24, 2025 / If you suffered a loss on your C3.ai, Inc. (NYSE:AI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/c3-ai-inc-lawsuit-submission-form?prid=163297&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Investors Urged to Contact Levi & Korsinsky for Information Before September 30, 2025 – Lineage, Inc. (LINE)

NEW YORK, NY / ACCESS Newswire / August 24, 2025 / If you suffered a loss on your Lineage, Inc. (NASDAQ:LINE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lineage-inc-lawsuit-submission-form?prid=163296&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

ROSEN, A GLOBAL AND LEADING FIRM, Encourages Flywire Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLYW

(NASDAQ:FLYW), NEW YORK, Aug. 24, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Flywire Corporation (NASDAQ: FLYW) between February 28, 2024 and February 25, 2025, both dates inclusive (the “Class Period”), of the important September 23, 2025 lead plaintiff deadline. SO WHAT: If you

ROSEN, A GLOBAL AND LEADING FIRM, Encourages Flywire Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLYW

ROSEN, A GLOBAL AND LEADING FIRM, Encourages Flywire Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLYW GlobeNewswire August 24, 2025 NEW YORK, Aug. 24, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Flywire Corporation (NASDAQ: FLYW) between February

ANRO ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Alto Neuroscience, Inc. – September 19, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / August 24, 2025 / If you suffered a loss on your Alto Neuroscience, Inc. (NYSE:ANRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/alto-neuroscience-inc-lawsuit-submission-form?prid=163299&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Securities Class Action Lawsuit Filed Against Sarepta Therapeutics, Inc. (SRPT) – Levi & Korsinsky Represents Shareholders

NEW YORK, NY / ACCESS Newswire / August 24, 2025 / If you suffered a loss on your Sarepta Therapeutics, Inc. (NASDAQ:SRPT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sarepta-lawsuit-submission-form?prid=163300&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Scroll to Top